dr. herbst on the development of biomarkers for lung cancer
Published 9 years ago • 66 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
3:16
dr herbst on the evolution of targeted therapies for egfr nsclc
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:01
dr. herbst on the international lung cancer congress
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
1:23
dr. herbst on targeting pd-1 and pd-l1 in lung cancer
-
0:58
dr. herbst on immunotherapy in lung cancer
-
2:03
the importance of biomarkers for lung cancer
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:26
dr. herbst on mpdl3280a for non-small cell lung cancer
-
1:35
dr. herbst on immuno-oncology combinations in lung cancer
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
1:03
dr. herbst on combination therapies for lung cancer
-
1:05
the challenge of biomarkers in lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials
-
1:13
dr. herbst on targeting pd-1 and pd-l1 in lung cancer
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
1:23
dr. herbst on themes from the 2011 lung cancer congress
-
1:59
dr. herbst on key immunotherapy findings in nsclc